Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival

被引:18
作者
Horie, Miho [1 ,2 ]
Salazar, Pascal [3 ]
Saito, Tomohito [4 ,5 ,6 ]
Binnie, Matthew [5 ]
Brock, Kristy [7 ]
Yasufuku, Kazuhiro [4 ,5 ]
Azad, Sassan [4 ]
Keshavjee, Shaf [2 ,5 ,6 ]
Martinu, Tereza [5 ]
Paul, Narinder [1 ,2 ]
机构
[1] Univ Toronto, Univ Hlth Network, Joint Dept Med Imaging, Toronto, ON, Canada
[2] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada
[3] Vital Images, Minnetonka, MN USA
[4] Univ Toronto, Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada
[5] Univ Toronto, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada
[6] Kansai Med Univ, Dept Thorac Surg, Hirakata, Osaka, Japan
[7] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
关键词
bronchiolitis obliterans syndrome; chronic lung allograft dysfunction; computed tomography; restrictive allograft syndrome; BRONCHIOLITIS OBLITERANS SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; TRANSPLANT RECIPIENTS; COMPUTED-TOMOGRAPHY; RISK; PROGRESSION; PHENOTYPE; ONSET;
D O I
10.1111/ctr.13233
中图分类号
R61 [外科手术学];
学科分类号
摘要
Chronic lung allograft dysfunction (CLAD) is a major cause of mortality in lung transplant recipients. CLAD can be sub-divided into at least 2 subtypes with distinct mortality risk characteristics: restrictive allograft syndrome (RAS), which demonstrates increased overall computed tomography (CT) lung density in contrast with bronchiolitis obliterans syndrome (BOS), which demonstrates reduced overall CT lung density. This study aimed to evaluate a reader-independent quantitative density metric (QDM) derived from CT histograms to associate with CLAD survival. A retrospective study evaluated CT scans corresponding to CLAD onset using pulmonary function tests in 74 patients (23 RAS, 51 BOS). Two different QDM values (QDM1 and QDM2) were calculated using CT lung density histograms. Calculation of QDM1 includes the extreme edges of the histogram. Calculation of QDM2 includes the central region of the histogram. Kaplan-Meier analysis and Cox regression analysis were used for CLAD prognosis. Higher QDM values were significantly associated with decreased survival. The hazard ratio for death was 3.2 times higher at the 75th percentile compared to the 25th percentile using QDM1 in a univariate model. QDM may associate with CLAD patient prognosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers
    Tissot, Adrien
    Danger, Richard
    Claustre, Johanna
    Magnan, Antoine
    Brouard, Sophie
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [42] Chronic lung allograft dysfunction phenotypes and treatment
    Verleden, Stijn E.
    Vos, Robin
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2650 - 2659
  • [43] Emerging biomarkers in chronic lung allograft dysfunction
    Shtraichman, Osnat
    Diamond, Joshua M.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (05) : 467 - 475
  • [44] Infectious Triggers of Chronic Lung Allograft Dysfunction
    Gregson, Aric L.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (07)
  • [45] Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction
    Gautschi, Fiorenza
    Vogelmann, Tobias
    Ortmanns, Gernot
    Knoerr, Fabian
    Steinack, Carolin
    Hage, Rene
    Naegeli, Mirjam
    Schuurmans, Mace Matthew
    JOURNAL OF CLINICAL APHERESIS, 2024, 39 (03)
  • [46] Chronic Lung Allograft Dysfunction: Oxygen-enhanced T1-Mapping MR Imaging of the Lung
    Renne, Julius
    Lauermann, Peer
    Hinrichs, Jan B.
    Schoenfeld, Christian
    Sorrentino, Sajoscha
    Gutberlet, Marcel
    Jakob, Peter
    Haverich, Axel
    Warnecke, Gregor
    Welte, Tobias
    Wacker, Frank K.
    Gottlieb, Jens
    Vogel-Claussen, Jens
    RADIOLOGY, 2015, 276 (01) : 266 - 273
  • [47] Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
    Iturbe-Fernandez, David
    Gafas, Alicia de Pablo
    Cuesta, Victor Manuel Mora
    Moralejo, Rodrigo Alonso
    Loaiza, Carlos Andres Quezada
    Perez Gonzalez, Virginia
    Lopez-Padilla, Daniel
    Cifrian, Jose M.
    LIFE-BASEL, 2024, 14 (05):
  • [48] Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction
    Schneeberger, Pierre H. H.
    Zhang, Chen Yang Kevin
    Santilli, Jessica
    Chen, Bo
    Xu, Wei
    Lee, Youngho
    Wijesinha, Zonelle
    Reguera-Nunez, Elaine
    Yee, Noelle
    Ahmed, Musawir
    Boonstra, Kristen
    Ramendra, Rayoun
    Frankel, Courtney W.
    Palmer, Scott M.
    Todd, Jamie L.
    Martinu, Tereza
    Coburn, Bryan
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (12) : 1495 - 1507
  • [49] High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome
    Hota, Partha
    Dass, Chandra
    Kumaran, Maruti
    Simpson, Scott
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (01) : W13 - W21
  • [50] Montelukast in chronic lung allograft dysfunction after lung transplantation
    Vos, Robin
    Vanden Eynde, Ruben
    Ruttens, David
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Dupont, Lieven J.
    Yserbyt, Jonas
    Verbeken, Eric K.
    Neyrinck, Arne P.
    Van Raemdonck, Dirk E.
    Verleden, Geert M.
    Godinas, Laurent
    Van Herck, Anke
    Vanstapel, Arno
    Sacreas, Annelore
    Kaes, Janne
    Heigl, Tobias
    Ordies, Sofie
    Schaevers, Veronique
    De Leyn, Paul
    Coosemans, Willy
    Nafteux, Philippe
    Decaluwe, Herbert
    Van Veer, Hans
    Depypere, Lieven
    Frick, Anna E.
    Ceulemans, Laurens J.
    Weynand, Birgit
    Emonds, Marie-Paule
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05) : 516 - 527